Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Cerbios-Pharma Investing in New High-Potency API Production Line and Conjugation Suite
By

By
  Gabriel HaeringCEOCerbios-Pharma SA Cerbios-Pharma SA, a Lugano, Switzerland-based contract development and manufacturing organization of chemical and biological active pharmaceutical ingredients (API), is expanding its high-potency API (HPAPI) production and…

Catalent Investing $214 Million to Expand Biologics Capabilities; Invests in Oral Delivery Capabilities
By

By
  Andrew SandfordVice President, Drug Substance & Biologics Analytical ServicesCatalent Pharma Solutions Catalent has announced multi-site investments to support its biologics and solid oral drug-delivery businesses. Andrew Sandford, Vice President,…

Cambrex Updates Integration of Halo Pharma and Avista Pharma; Expands Small-Molecule API Mfg
By

By
  Shawn P. CavanaghExecutive Vice President, and Chief Operating OfficerCambrex Corporation Shawn P. Cavanagh, Executive Vice President and Chief Operating Officer, Cambrex, provided an update on the integration of the…

BSP To Add High-Containment Capacity for Conjugation and Injectable Drug Products
By

By
  Aldo BracaPresident and CEOBSP Pharmaceuticals SpA BSP Pharmaceuticals, a Latina Scalo, Italy-based contract development and manufacturing organization of oral solid dosage forms and injectables, is expanding high-containment capacity dedicated…

ACG Expands Capsule Production in Brazil, India, and Croatia
By

By
  Kamlesh Oza, PhDSenior Vice PresidentACG ACG has launched a new capsule manufacturing facility in Brazil and is expanding capsule production at its facilities in Croatia and India. Kamlesh Oza,…

DCAT EVENT NEWS
By

By
DCAT Returns to Frankfurt for DCAT After The Show in 2022 What has been the impact of COVID-19 on bio/pharmaceutical companies’bottom line?

PEOPLE ON THE MOVE
By

By
View the latest movements of employees at DCAT Member Companies

INTERVIEW
By

By
Five Minutes with Joe Sutton, Director, Global Development and Manufacturing Procurement, Eli Lilly and Company What has been the impact of COVID-19 on bio/pharmaceutical bottom line?

Etiam Ante Sem Enim Ipsum Amet Eros Ligula Ullamcorper Vivamus Eu
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Nisi Dolor Etiam Eleifend Pretium Libero Quis Amet Nam Vel A Consequat Penatibus
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…